Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: An analysis of transgenic mice

Journal of Bone and Mineral Research

Volumn 19, Issue 1, 2004, Pages 78-88

  Higashibata, Yuji ^a   Sakuma, Takahiko ^a   Kawahata, Hirohisa ^a   Fujihara, Shinji ^b   Moriyama, Keiji ^b   Okada, Atsushi ^c   Yasui, Takahiro ^c   Kohri, Kenjiro ^c   Kitamura, Yukihiko ^a   Nomura, Shintaro ^a,d  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cis acting element; Green fluorescent protein; Osteopontin; Promoter; Transgenic mice

Indexed keywords

CIS ACTING ELEMENT; GREEN FLUORESCENT PROTEIN; OSTEOPONTIN; HYBRID PROTEIN; PHOTOPROTEIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BREAST DEVELOPMENT; CARTILAGE CELL; CELL MATURATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FLUORESCENCE ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; KIDNEY DEVELOPMENT; KIDNEY EPITHELIUM; MAMMARY GLAND; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; PLACENTA DEVELOPMENT; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; TISSUE SPECIFICITY; TRANSGENIC MOUSE; ANIMAL; BIOLOGICAL MODEL; BONE; C57BL MOUSE; CARTILAGE; CHEMISTRY; CROSS BREEDING; CYTOLOGY; DBA MOUSE; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; LEG; METABOLISM; PLACENTA; PREGNANCY; REGULATORY SEQUENCE; SKIN; SOUTHERN BLOTTING; SPINE; UDDER; WESTERN BLOTTING;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BONE AND BONES; CARTILAGE; CROSSES, GENETIC; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; LEG BONES; LUMINESCENT PROTEINS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MODELS, GENETIC; OSTEOPONTIN; PLACENTA; PREGNANCY; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SIALOGLYCOPROTEINS; SKIN; SPINE;

EID: 4644360517     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2004.19.1.78     Document Type: Article

References (43)

1. Franzen A, Heinegard D 1985 Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J232:715-724.
2. Pepinsky RB, Mumford RA, Chen LL, Leone D, Amo SE, Riper GV, Whitty A, Dolimski B, Lobb RR, Dean DC, Chang LL, Raab CE, Si Q, Hagman WK, Lingham RB 2002 Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1. Biochemistry 41:7125-7141.
3. Weber GF, Ashkar S, Glimcher MJ, Cantor H 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
4. Reinholt FP, Hultenby K, Oldberg A, Heinegard D 1990 Osteopontin-a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475.
5. Denhardt DT, Guo X 1993 Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482.
6. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BL 1988 Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 106:441-450.
7. Nakase T, Takaoka K, Hirakawa K, Hirota S, Takemura T, Onoue H, Takebayashi K, Kitamura Y, Nomura S 1994 Alterations in the expression of osteonectin, osteopontin and osteocalcin mRNAs during the development of skeletal tissues in vivo. Bone Miner 26:109-122.
8. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H 1990 Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171:1931-1942.
9. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S 1990 The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 265:14432-14438.
10. Takemura T, Sakagami M, Nakase T, Kubo T, Kitamura Y, Nomura S 1994 Localization of osteopontin in the otoconial organs of adult rats. Hear Res 79:99-104.
11. Rittling SR, Novick KE 1997 Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ8:1061-1069.
12. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S 1993 Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol 143:1003-1008.
13. Hirota S, Ito A, Nagoshi J, Takeda M, Kurata A, Takatsuka Y, Kohri K, Nomura S, Kitamura Y 1995 Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. Lab Invest 72:64-69.
14. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Sinohara H, Kurita T 1993 Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184.
15. Yoshitake H, Rittling SR, Denhardt DT, Noda M 1999 Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156-8160.
16. Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M 2001 Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193:399-404.
17. Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, Hruska KA, Higashio K, Enomoto S, Nifuji A, Rittling SR, Noda M 2001 Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem 276:13065-13071.
18. Terai K, Takano-Yamamoto T, Ohba Y, Hiura K, Sugimoto M, Sato M, Kawahata H, Inaguma N, Kitamura Y, Nomura S 1999 Role of osteopontin in bone remodeling caused by mechanical stress. J Bone Miner Res 14:839-849.
19. Blackwood EM, Kadonaga JT 1998 Going the distance: A current view of enhancer action. Science 281:61-63.
20. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT 1990 Identification of a DNA sequence responsible for binding of the 1, 25 dihydroxy vitamin D3 receptor and 1, 25-dthydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999.
21. Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S 1998 Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517-1525.
22. Nomura S, Sakuma T, Higashibata Y, Oboki K, Sato M 2001 Molecular cause of the severe functional deficiency in osteoclasts by an arginine deletion in the basic domain of Mi transcription factor. J Bone Miner Metab 19:183-187.
23. Bai S, Shi X, Yang X, Cao X 2000 Smad6 as a transcriptional corepressor. J Biol Chem 275:8267-8270.
24. Bogdanovic Z, Bedalov A, Krebsbach PH, Pavlin D, Woody CO, Clark SH, Thomas HF, Rowe DW, Kream BE, Lichtler AC 1994 Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J Bone Miner Res9:285-292.
25. Khillan JS, Schmidt A, Overbeek PA, de Crombrugghe B, Westphal H 1986 Developmental and tissue-specific expression directed by the alpha 2 type I collagen promoter in transgenic mice. Proc Natl Acad Sci USA 83:725-729.
26. Zhou G, Garofalo S, Mukhopadhyay K, Lefebvre V, Smith CN, Eberspaecher H, de Crombrugghe B 1995 A 182 bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J Cell Sci 108:3677-3684.
27. Braghetta P, Fabbro C, Piccolo S, Marvulli D, Bonaldo P, Volpin D, Bressan GM 1996 Distinct regions control transcriptional activation of the alphal(VI) collagen promoter in different tissues of transgenic mice. J Cell Biol 135:1163-1177.
28. Braghetta P, Vitale P, Piccolo S, Bonaldo P, Fabbro C, Girotto D, Volpin D, Bressan GM 1997 Tissue-specific expression of promoter regions of the alphal(VI) collagen gene in cell cultures and transgenic mice. Eur J Biochem 247:200-208.
29. Eerola I, Elima K, Markkula M, Kananen K, Vuorio E 1996 Tissue distribution and phenotypic consequences of different type X collagen gene constructs in transgenic mice. Ann NY Acad Sci 785:248-250.
30. Liu Y, Li H, Tanaka K, Tsumaki N, Yamada Y 2000 Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collacen gene. J Biol Chem 275:12712-12718.
31. Tsumaki N, Liu Y, Yamada Y, Krebsbach P 2000 Enhancer analysis of the alpha 1(II) and alpha 2(XI) collagen genes in transfected chondrocytes and transgenic mice. Methods Mol Biol 139:187-195.
32. Chen J, Thomas HF, Jin H, Jiang H, Sodek J 1996 Expression of rat bone sialoprotein promoter in transgenic mice. J Bone Miner Res 11:654-664.
33. Kesterson RA, Stanley L, DeMayo F, Finegold M, Pike JW 1993 The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice. Mol Endocrinol 7:462-467.
34. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y 1997 Green mice as a source of ubiquitous green cells. FEBS Lett 407:313-319.
35. Chirgwin JM, Przybula AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
36. Takebayashi K, Chida K, Tsukamoto I, Morii E, Munakata H, Arnheiter H, Kuroki T, Kitamura Y, Nomura S 1996 The recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nucleation potential. Mol Cell Biol 16:1203-1211.
37. Hirakawa K, Hirota S, Ikeda T, Yamaguchi A, Takemura T, Nagoshi J, Yoshiki S, Suda T, Kitamura Y, Nomura S 1994 Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization. J Bone Miner Res 9:1551-1557.
38. Sato M, Yasui N, Nakase T, Kawahata H, Sugimoto M, Hirota S, Kitamura Y, Nomura S, Ochi T 1998 Expression of bone matrix proteins mRNA during distraction osteogenesis. J Bone Miner Res 13:1221-1231.
39. Barnes GL, Della Torre T, Sommer B, Young MF, Gerstenfeld LC 2002 Transcriptional regulation restricting bone sialoprotein gene expression to both hypertrophic chondrocytes and osteoblasts. J Cell Biochem 87:458-469.
40. Taniyama Y, Sato K, Sugawara A, Uruno A, Ikeda Y, Kudo M, Ito S, Takeuchi K 2001 Renal tubule-specific transcription and chromosomal localization of rat thiazide-sensitive Na-Cl cotransporter gene. J Biol Chem 276:26260-26268.
41. Sakuma T, Higashibata Y, Kawahata H, Yamada S, Okabe M, Kitamura Y, Nomura S 2003 Difference of osteopontin gene regulation between bone and kidney. J Orthop Sci 8:361-366.
42. Bedalov A, Salvatori R, Dodig M, Kronenberg MS, Kapural B, Bogdanovic Z, Kream BE, Woody CO, Clark SH, Mack K, Rowe DW Lichtler AC 1995 Regulation of COL1A1 expression in type I collagen producing tissues: Identification of a 49 base pair region which is required for transgene expression in bone of transgenic mice. J Bone Miner Res 10:1443-1451.
43. Dodig M, Kronenberg MS, Bedalov A, Kream BE, Gronowicz G, Clark SH, Mack K, Liu YH, Maxon R, Pan ZZ, Upholt WB, Rowe DW, Lichtler AC 1996 Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J Biol Chem 271:16422-16429.